Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–3 of 3 results
Advanced filters: Author: Utsarga Adhikary Clear advanced filters
  • Resistance mutations in BCL-2 reduce the clinical efficacy of venetoclax. DeAngelo et al. show stapled BAD BH3 peptides can retain and even enhance binding to these mutants, offering a structurally informed strategy to overcome this mechanism of cancer drug resistance.

    • Thomas M. DeAngelo
    • Utsarga Adhikary
    • Loren D. Walensky
    ResearchOpen Access
    Nature Communications
    Volume: 16, P: 1-15
  • A disulfide tethering screen identified a molecule that covalently interacts with pro-apoptotic BAX at C126, inhibiting its activation.

    • Matthew W. McHenry
    • Peiwen Shi
    • Loren D. Walensky
    Research
    Nature Chemical Biology
    Volume: 20, P: 1022-1032